| Website | amvac.ch |
| Category | BioTech |
| Phone | +41 41 725 32 30 |
| info@amvac.ch | |
| Employees | |
| Founded | 2005 |
| TOTAL | $2.8M |
| FUNDING TOTAL | $2.8M |
| Series A, 2/10 Venture+ | $2.8M |
AmVac AG is a biopharmaceutical company with a clear strategic focus on the development and subsequent commercialization of innovative immune therapies and prophylactic vaccines. The head office of the company is in Zug, Switzerland. Creating new therapies for the indication areas gynecology, urology and respiratory diseases are at the core of AmVac’s strategy.
